{
    "nctId": "NCT01811199",
    "briefTitle": "Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2\u03b1 and LTC4 Levels",
    "officialTitle": "Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2\u03b1 and LTC4 Levels",
    "overallStatus": "UNKNOWN",
    "conditions": "Thyroid Cancer, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Number of participants will be evaluated to show effect of dexamethasone in reducing postoperative emesis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast and thyroid cancer patients no neoadjuvant treated no NSAID or steroid usage heallthy volunteers, signed the informed consent\n\nExclusion Criteria:\n\n* ones who did not sign the consent form NSAID or steroid users",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}